{"doi":"10.1192\/bjp.184.6.509","coreId":"206886","oai":"oai:eprints.lse.ac.uk:15904","identifiers":["oai:eprints.lse.ac.uk:15904","10.1192\/bjp.184.6.509"],"title":"Non-adherence to antipsychotic medication regimens: associations with resource use and costs","authors":["Knapp, Martin","King, Derek","Pugner, Klaus","Lapuerta, Pablo"],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2004-06","abstract":"Background: Several factors are thought to influence resource use and costs in treating schizophrenia.\\ud\n\\ud\nAims: To assess the relative impact of non-adherence and other factors associated with resource use and costs incurred by people with schizophrenia.\\ud\n\\ud\nMethod: Secondary analyses were made of data from a 1994 national survey of psychiatric morbidity among adults living in institutions in the UK. Factors potentially relating to resource use and costs were examined using two-part models.\\ud\n\\ud\nResults: Patients who failed to adhere to their medication regimen were over one-and-a-half times as likely as patients who did adhere to it to report use of in-patient services. Non-adherence is one of the most significant factors in increasing external service costs, by a factor of almost 3. Non-adherence predicted an excess annual cost per patient of approximately \u00a32500 for in-patient services and over \u00a35000 for total service use.\\ud\n\\ud\nConclusions: Resource use and costs are influenced by various factors. Medication non-adherence consistently exhibits an association with higher costs. Further important factors are patient needs and the ability of the system to address them","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"Royal College of Psychiatrists","rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:eprints.lse.ac.uk:15904<\/identifier><datestamp>\n      2012-05-30T08:40:12Z<\/datestamp><setSpec>\n      74797065733D4445505453:4C53452D5341<\/setSpec><setSpec>\n      74797065733D434F4C4C53:4C53455F435F454F<\/setSpec><setSpec>\n      74797065733D43454E54524553:4C53455F52435F3536<\/setSpec><setSpec>\n      74797065733D43454E54524553:4C53455F52435F3839<\/setSpec><\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:relation>\n    \n      \n        http:\/\/eprints.lse.ac.uk\/15904\/<\/dc:relation><dc:title>\n        Non-adherence to antipsychotic medication regimens: associations with resource use and costs<\/dc:title><dc:creator>\n        Knapp, Martin<\/dc:creator><dc:creator>\n        King, Derek<\/dc:creator><dc:creator>\n        Pugner, Klaus<\/dc:creator><dc:creator>\n        Lapuerta, Pablo<\/dc:creator><dc:subject>\n        HC Economic History and Conditions<\/dc:subject><dc:subject>\n        RM Therapeutics. Pharmacology<\/dc:subject><dc:description>\n        Background: Several factors are thought to influence resource use and costs in treating schizophrenia.\\ud\n\\ud\nAims: To assess the relative impact of non-adherence and other factors associated with resource use and costs incurred by people with schizophrenia.\\ud\n\\ud\nMethod: Secondary analyses were made of data from a 1994 national survey of psychiatric morbidity among adults living in institutions in the UK. Factors potentially relating to resource use and costs were examined using two-part models.\\ud\n\\ud\nResults: Patients who failed to adhere to their medication regimen were over one-and-a-half times as likely as patients who did adhere to it to report use of in-patient services. Non-adherence is one of the most significant factors in increasing external service costs, by a factor of almost 3. Non-adherence predicted an excess annual cost per patient of approximately \u00a32500 for in-patient services and over \u00a35000 for total service use.\\ud\n\\ud\nConclusions: Resource use and costs are influenced by various factors. Medication non-adherence consistently exhibits an association with higher costs. Further important factors are patient needs and the ability of the system to address them.<\/dc:description><dc:publisher>\n        Royal College of Psychiatrists<\/dc:publisher><dc:date>\n        2004-06<\/dc:date><dc:type>\n        Article<\/dc:type><dc:type>\n        PeerReviewed<\/dc:type><dc:identifier>\n          Knapp, Martin and King, Derek and Pugner, Klaus and Lapuerta, Pablo  (2004) Non-adherence to antipsychotic medication regimens: associations with resource use and costs.  British Journal of Psychiatry, 184 (6).  pp. 509-516.  ISSN 0007-1250     <\/dc:identifier><dc:relation>\n        http:\/\/bjp.rcpsych.org<\/dc:relation><dc:relation>\n        10.1192\/bjp.184.6.509<\/dc:relation><\/oai_dc:dc><\/metadata><\/record>","journals":null,"language":null,"relations":["http:\/\/eprints.lse.ac.uk\/15904\/","http:\/\/bjp.rcpsych.org","10.1192\/bjp.184.6.509"],"year":2004,"topics":["HC Economic History and Conditions","RM Therapeutics. Pharmacology"],"subject":["Article","PeerReviewed"],"fullText":null}